Showing 4021-4030 of 7016 results for "".
- Targeting YAP and TAZ Proteins: Advancing Pulmonary Fibrosis Treatmentshttps://reachmd.com/news/targeting-yap-and-taz-proteins-advancing-pulmonary-fibrosis-treatments/2471230/Recent breakthroughs emphasize the essential function of YAP and TAZ proteins in pulmonary fibrosis, presenting new avenues for therapeutic interventions to tackle this challenging lung condition. YAP/TAZ Signaling in Pulmonary Fibrosis
- Navigating Parenthood: Reproductive Outcomes for Young Male Cancer Survivorshttps://reachmd.com/news/navigating-parenthood-reproductive-outcomes-for-young-male-cancer-survivors/2471278/Navigating Parenthood: Reproductive Outcomes for Young Male Cancer Survivors A groundbreaking study reveals that male adolescents and young adults who survive cancer face slightly elevated risks of preterm births and low-birth-weight children, highlighting crucial
- POETYK-PSO LTE: No New Safety Signals for Deucravacitinib at Five Yearshttps://reachmd.com/news/poetyk-lte-no-new-safety-signals-for-deucravacitinib-at-five-years/2471170/Sotyktu (deucravacitinib) showed sustained efficacy and an acceptable safety profile over a period of 5 years in adults with moderate-to-severe plaque psoriasis, according to an announcement by Bristol Myers Squibb. Based on rec
- The Impact of Yo-Yo Dieting on Kidney Health in Type 1 Diabetes Patientshttps://reachmd.com/news/the-impact-of-yo-yo-dieting-on-kidney-health-in-type-1-diabetes-patients/2471159/What's New New evidence links yo-yo dieting to an increased risk of kidney disease in patients with Type 1 diabetes, highlighting the importance of weight stability. Significance The findings underscore the need for healthcare professionals to guide
- The Impact of Work on Young Adults' Health Behaviors: New Insightshttps://reachmd.com/news/the-impact-of-work-on-young-adults-health-behaviors-new-insights/2471049/What's New Recent research from the University of Cambridge has shed light on the health behavior shifts young adults experience when they start working. These changes, particularly in physical activity and sleep patterns, vary depending on the nature of their jobs.
- Lingering Shadows: Pandemic's Lasting Mental Health Impact on Youthhttps://reachmd.com/news/lingering-shadows-pandemics-lasting-mental-health-impact-on-youth/2470955/What's New Newly published studies reveal ongoing mental health challenges among youth, with increased rates of anxiety and depression persisting years after the COVID-19 pandemic. Significance Understanding the persistent mental health challenges fa
- Rising Trend of Gastric Cancer Among Younger Adults: An Urgent Health Concernhttps://reachmd.com/news/rising-trend-gastric-cancer-among-younger-adults-urgent-health-concern/2470880/What's New Recent findings from a comprehensive global study reveal that gastric cancer, historically prevalent in older adults, is now rising among younger populations. The study highlights the need for targeted preventive measures and early detection strategies.</
- New Discovery in Crohn's Disease: Yersiniabactin's Role in Intestinal Fibrosishttps://reachmd.com/news/new-discovery-crohns-disease-yersiniabactins-role-intestinal-fibrosis/2470787/What's New Researchers have identified yersiniabactin, a small molecule produced by E. coli, as a key driver of fibrosis in Crohn's disease by altering zinc levels and activating macrophages. Significance This finding is significant because it opens new ave
- Neurologic Manifestations of Long COVID Disproportionately Affect Younger and Middle-Age Adultshttps://reachmd.com/news/neurologic-manifestations-of-long-covid-disproportionately-affect-younger-and-middle-age-adults/2470669/Younger and middle-aged adults appear to be disproportionately impacted by neurologic symptoms of long COVID, according to a study published in the Annals of Neurology. The findings reveal unique age-related differences in symptom burden, cognitive performance, and quality of life, parti
- Deucravacitinib Demonstrates Long-Term Safety and Efficacy in Plaque Psoriasis Over 3 Yearshttps://reachmd.com/news/deucravacitinib-demonstrates-long-term-safety-and-efficacy-in-plaque-psoriasis-over-3-years/2470673/Oral deucravacitinib, a treatment for moderate to severe plaque psoriasis, has demonstrated sustained efficacy and a favorable safety profile over three years, according to a new study published in JAMA Dermatology. The findings combine data from the POETYK PSO-1 and PSO-2 randomized tri